Dakota Wealth Management Reduces Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Dakota Wealth Management trimmed its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 7.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 49,316 shares of the real estate investment trust’s stock after selling 4,219 shares during the period. Dakota Wealth Management’s holdings in Sabra Health Care REIT were worth $854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also made changes to their positions in SBRA. Principal Financial Group Inc. boosted its holdings in Sabra Health Care REIT by 0.8% in the third quarter. Principal Financial Group Inc. now owns 21,573,436 shares of the real estate investment trust’s stock valued at $401,479,000 after purchasing an additional 167,069 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Sabra Health Care REIT by 222.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after buying an additional 6,819,919 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Sabra Health Care REIT by 1.7% in the 3rd quarter. Geode Capital Management LLC now owns 6,294,798 shares of the real estate investment trust’s stock valued at $117,165,000 after buying an additional 104,533 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Sabra Health Care REIT by 8.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,701,881 shares of the real estate investment trust’s stock worth $87,502,000 after acquiring an additional 365,855 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in Sabra Health Care REIT by 3.8% in the second quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock valued at $52,275,000 after acquiring an additional 124,825 shares during the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Health Care REIT Stock Up 1.0 %

SBRA stock opened at $16.92 on Friday. The stock has a market capitalization of $4.00 billion, a PE ratio of 41.27, a price-to-earnings-growth ratio of 2.00 and a beta of 1.26. The company has a fifty day moving average of $17.51 and a 200-day moving average of $17.56. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. Sabra Health Care REIT, Inc. has a one year low of $12.83 and a one year high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The firm had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the previous year, the business earned $0.34 EPS. As a group, analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 7.09%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 292.69%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SBRA. Wells Fargo & Company raised Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $16.00 to $20.00 in a report on Tuesday, October 1st. Mizuho reaffirmed a “neutral” rating and set a $20.00 price target on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Tuesday, January 7th. Truist Financial cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and cut their target price for the company from $18.00 to $17.00 in a report on Friday, January 17th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $19.13.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.